1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 1: 
Clinical and imaging characteristics and outcome in 12 patients
Age/Sex NIHSS Score on Admission Occlusion Site Time to IV rtPA (min) Time to IA Therapy (min) Duration of Procedure (min) Urokinase Dose (× 10⁴ U) TICI Grade NIHSS at Discharge Symptomatic Hemorrhage mRS at 3 Months
70/M 13 MCA 115 170 60 40 III 6 No 1
79/M 20 MCA 123 270 75 20 IIc 2 No 1
34/F 19 BA 108 170 70 30 IIb 3 No 1
73/M 20 ICAT 120 220 40 40 IIa 9 No 4
69/F 17 MCA 127 240 70 30 IIc 1 No 1
45/M 11 MCA 90 240 44 15 IIb 4 No 2
72/M 13 MCA 97 240 30 30 III 0 No 0
72/M 17 ICAT 175 300 30 30 IIc 6 No 5
76/M 13 MCA 130 190 50 30 III 1 No 1
51/M 14 MCA 130 250 80 40 IIc 1 No 1
64/F 23 BA 75 190 80 30 IIc 2 No 1
53/F 18 MCA 120 185 45 45 IIb 12 No 5

Note:—NIHSS indicates the National Institutes of Health Stroke scale; M, male; F, female; MCA, middle cerebral artery; BA, basilar artery; ICAT, internal carotid artery T-bifurcation; IV, intravenous; rtPA, recombinant tissue plasminogen activator; IA, intra-arterial; TICI, Thrombolysis in Cerebral Ischemia; mRS, modified Rankin scale.